These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 31216262)

  • 41. ABCB1-overexpressing MG63/DOX cell xenograft model: maintain the MDR phenotype in vivo.
    Zhou Z; Wan L; Han Y; Meng X; Yang Q; Li Y; Yu Q; Shen Z; Guo C
    Pharm Biol; 2013 Aug; 51(8):968-73. PubMed ID: 23735077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The disintegrin echistatin in combination with doxorubicin targets high-metastatic human osteosarcoma overexpressing ανβ3 integrin in chick embryo and nude mouse models.
    Tome Y; Kimura H; Sugimoto N; Tsuchiya H; Kanaya F; Bouvet M; Hoffman RM
    Oncotarget; 2016 Dec; 7(52):87031-87036. PubMed ID: 27894082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.
    Ma H; He C; Cheng Y; Li D; Gong Y; Liu J; Tian H; Chen X
    Biomaterials; 2014 Oct; 35(30):8723-34. PubMed ID: 25017095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line.
    Kubiliūtė R; Šulskytė I; Daniūnaitė K; Daugelavičius R; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(5):298-306. PubMed ID: 27746118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ZEB1 knockdown mediated using polypeptide cationic micelles inhibits metastasis and effects sensitization to a chemotherapeutic drug for cancer therapy.
    Fang S; Wu L; Li M; Yi H; Gao G; Sheng Z; Gong P; Ma Y; Cai L
    Nanoscale; 2014 Sep; 6(17):10084-94. PubMed ID: 25032749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. pH-responsive mesoporous ZSM-5 zeolites/chitosan core-shell nanodisks loaded with doxorubicin against osteosarcoma.
    Yang F; Wen X; Ke QF; Xie XT; Guo YP
    Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():142-153. PubMed ID: 29407142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1.
    Liu C; Lin J
    Am J Transl Res; 2016; 8(10):4095-4105. PubMed ID: 27829995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pirarubicin-based versus doxorubicin-based osteosarcoma chemotherapy.
    Shinozaki T; Watanabe H; Yanagawa T; Shirakura K; Takagishi K
    Ann Pharmacother; 2002 Jun; 36(6):996-9. PubMed ID: 12022899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway.
    Yao Y; Chen R; Ying C; Zhang G; Rui T; Tao A
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1288-1295. PubMed ID: 28965952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice.
    Ye J; Huang Y; Que B; Chang C; Liu W; Hu H; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Zhen W; Xu Y; Shi L; Liu J; Jiang H; Ye D; Lin Y; Wan J; Ji Q
    EBioMedicine; 2018 Sep; 35():29-39. PubMed ID: 30228093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma.
    Ma Z; Guo D; Wang Q; Liu P; Xiao Y; Wu P; Wang Y; Chen B; Liu Z; Liu Q
    Theranostics; 2019; 9(10):2967-2983. PubMed ID: 31244936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantification of the expression of multidrug resistance-related genes in human tumour cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres.
    Laurand A; Laroche-Clary A; Larrue A; Huet S; Soma E; Bonnet J; Robert J
    Anticancer Res; 2004; 24(6):3781-8. PubMed ID: 15736412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HOTAIR promotes osteosarcoma development by sponging miR-217 and targeting ZEB1.
    Wang B; Qu XL; Liu J; Lu J; Zhou ZY
    J Cell Physiol; 2019 May; 234(5):6173-6181. PubMed ID: 30367466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel Approach on Drug Delivery: Investigation of A New Nano-Formulation of Liposomal Doxorubicin and Biological Evaluation of Entrapped Doxorubicin on Various Osteosarcoma Cell Lines.
    Haghiralsadat F; Amoabediny G; Sheikhha MH; Forouzanfar T; Helder MN; Zandieh-Doulabi B
    Cell J; 2017; 19(Suppl 1):55-65. PubMed ID: 28580308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    Cancer Lett; 1998 Apr; 126(1):75-81. PubMed ID: 9563651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
    Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
    Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1).
    Yan X; Zhao J; Zhang R
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):395-403. PubMed ID: 28667355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Autophagy is involved in doxorubicin induced resistance of human myeloma cell line RPMI8226].
    Pan YZ; Wang X; Bai H; Wang CB; Zhang Q; Xi R
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):489-92. PubMed ID: 23827103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways.
    Maayah ZH; Zhang T; Forrest ML; Alrushaid S; Doschak MR; Davies NM; El-Kadi AOS
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30181466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of ZEB1 on regulating osteosarcoma cells via NF-κB/iNOS.
    Xu XM; Liu W; Cao ZH; Liu MX
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1184-1190. PubMed ID: 28387915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.